AU2003292219A8 - Devices coated with substances that mediate the adhesion of biological material - Google Patents

Devices coated with substances that mediate the adhesion of biological material

Info

Publication number
AU2003292219A8
AU2003292219A8 AU2003292219A AU2003292219A AU2003292219A8 AU 2003292219 A8 AU2003292219 A8 AU 2003292219A8 AU 2003292219 A AU2003292219 A AU 2003292219A AU 2003292219 A AU2003292219 A AU 2003292219A AU 2003292219 A8 AU2003292219 A8 AU 2003292219A8
Authority
AU
Australia
Prior art keywords
mediate
adhesion
biological material
substances
devices coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003292219A
Other versions
AU2003292219A1 (en
Inventor
Hermann Schlusener
Hans-Peter Wendel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eberhard Karls Universitaet Tuebingen
Original Assignee
Eberhard Karls Universitaet Tuebingen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eberhard Karls Universitaet Tuebingen filed Critical Eberhard Karls Universitaet Tuebingen
Publication of AU2003292219A1 publication Critical patent/AU2003292219A1/en
Publication of AU2003292219A8 publication Critical patent/AU2003292219A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Devices having at least one surface which comes into contact with tissues and/or fluids of the human or animal body. These surfaces are at least partially coated with aptamers, which mediate the adhesion of biological material.
AU2003292219A 2002-12-17 2003-12-10 Devices coated with substances that mediate the adhesion of biological material Abandoned AU2003292219A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10258924A DE10258924A1 (en) 2002-12-17 2002-12-17 Device coated with the adhesion of substances imparting biological material
DE10258924.0 2002-12-17
PCT/EP2003/013989 WO2004055153A2 (en) 2002-12-17 2003-12-10 Devices coated with substances that mediate the adhesion of biological material

Publications (2)

Publication Number Publication Date
AU2003292219A1 AU2003292219A1 (en) 2004-07-09
AU2003292219A8 true AU2003292219A8 (en) 2004-07-09

Family

ID=32477709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003292219A Abandoned AU2003292219A1 (en) 2002-12-17 2003-12-10 Devices coated with substances that mediate the adhesion of biological material

Country Status (7)

Country Link
US (1) US20060068416A1 (en)
EP (1) EP1572027B1 (en)
AT (1) ATE497737T1 (en)
AU (1) AU2003292219A1 (en)
DE (2) DE10258924A1 (en)
ES (1) ES2360387T3 (en)
WO (1) WO2004055153A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220276B1 (en) * 2000-03-06 2007-05-22 Surmodics, Inc. Endovascular graft coatings
DE102006026191A1 (en) * 2006-05-26 2007-11-29 Eberhard-Karls-Universität Tübingen Universitätsklinikum Device useful for isolating mesenchymal stem cells from biological tissues or fluids is coated with an aptamer that mediates binding of such cells
WO2008034627A2 (en) * 2006-09-22 2008-03-27 Biosteel Medical Han/Sellin Gbr Coated implant
WO2008034474A2 (en) * 2006-09-22 2008-03-27 Jin-Cheol Kim Coated stent
US20090042237A1 (en) * 2007-08-06 2009-02-12 Henry John Smith Aptamer based point-of-care test for glycated albumin
US20090047318A1 (en) * 2007-08-16 2009-02-19 Abbott Cardiovascular Systems Inc. Nanoparticle-coated medical devices and formulations for treating vascular disease
DE102007050668A1 (en) * 2007-10-24 2009-04-30 Biotronik Vi Patent Ag Stent with a base made of a bioinert metallic implant material
DE102008008263A1 (en) 2008-02-08 2009-08-13 Thomas Kuczera Percutaneous transluminal coronary angioplasty catheter with a coating, useful e.g. to treat restenosis, comprises amino-/carboxyl-functional group, oligonucleotides, microbodies, C-type natriuretic peptide, proteins and/or oligopeptide
DE202008006190U1 (en) 2008-05-06 2008-07-17 Sellin, Lothar restenosis prophylaxis
DE102008040573A1 (en) * 2008-07-21 2010-01-28 Biotronik Vi Patent Ag Implant, preferably brain pacemaker useful for treating Parkinson's disease, comprises an implant base body, anchor groups on the surface of the implant base body, and aptamers, which are bonded to the anchor groups
CA2769878A1 (en) 2008-08-07 2010-02-11 Bioactive Surgical, Inc. Stem cell capture and immobilization coatings for medical devices and implants
DE102009059070A1 (en) 2008-12-19 2010-07-01 Lothar Sellin Medical device e.g. percutaneous transluminal coronary angioplasty catheter, for direct application of C-type natriuretic peptide on blood vessel wall, has base body with coating, where device consists of C-type natriuretic peptide
EP2338537A2 (en) 2009-12-21 2011-06-29 Biotronik VI Patent AG Aptamer coated implant, process of production and uses
US9476043B2 (en) 2011-04-08 2016-10-25 Rula Zain-Luqman Diagnosis and treatment of friedreich's ataxia
FR2983212A1 (en) * 2011-11-28 2013-05-31 Lfb Biotechnologies ANTI-FH APTAMERS, PROCESS FOR OBTAINING THEM AND USES THEREOF
KR101473467B1 (en) * 2013-05-29 2014-12-18 재단법인 전남생물산업진흥원 Nucleic Acid Aptamer Capable of Specifically Binding to cRGD Positive Endothelial Progenitor Cell and Use Thereof
US20150038948A1 (en) * 2013-07-31 2015-02-05 G-Tech Electronic Research & Development, LLC Apparatus and use of a neurochemisrty regulator device insertable in the cranium for the treatment of cerebral cortical disorders
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
US10309975B2 (en) 2014-08-21 2019-06-04 University Of Central Florida Research Foundation, Inc. Functionalized eyewear device for detecting biomarker in tears
KR101583578B1 (en) * 2014-10-29 2016-01-13 재단법인 전남생물산업진흥원 Nucleic Acid Aptamer Capable of Specifically Binding to cRGD Positive Endothelial Progenitor Cell and Use Thereof
DE202015002048U1 (en) 2015-03-16 2015-09-24 Han Bock-Sun implant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840867A (en) * 1991-02-21 1998-11-24 Gilead Sciences, Inc. Aptamer analogs specific for biomolecules
US6429199B1 (en) * 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
DE19745668A1 (en) * 1996-10-17 1998-04-23 Scheller Frieder Prof Coupling of bio-technological functional units
DE19755801A1 (en) * 1997-12-16 2000-06-21 Merck Patent Gmbh Implant with improved tissue integration
US6287765B1 (en) * 1998-05-20 2001-09-11 Molecular Machines, Inc. Methods for detecting and identifying single molecules
DE10019154A1 (en) * 2000-04-18 2001-10-31 Univ Eberhard Karls Cell-binding nucleic acid molecules (aptamers)
WO2001092566A2 (en) * 2000-05-26 2001-12-06 Noxxon Pharma Ag Immobilized nucleic acids and uses thereof
US20030050268A1 (en) * 2001-03-29 2003-03-13 Krieg Arthur M. Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
US20030082148A1 (en) * 2001-10-31 2003-05-01 Florian Ludwig Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo

Also Published As

Publication number Publication date
WO2004055153A2 (en) 2004-07-01
EP1572027A2 (en) 2005-09-14
AU2003292219A1 (en) 2004-07-09
ES2360387T3 (en) 2011-06-03
US20060068416A1 (en) 2006-03-30
ATE497737T1 (en) 2011-02-15
WO2004055153A3 (en) 2005-05-12
EP1572027B1 (en) 2011-02-09
DE10258924A1 (en) 2004-07-08
DE50313465D1 (en) 2011-03-24

Similar Documents

Publication Publication Date Title
AU2003292219A8 (en) Devices coated with substances that mediate the adhesion of biological material
ZA200004569B (en) Infusion of liquids into the human or animal body.
AU314701S (en) Body fluid assay device
WO2009009173A3 (en) Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
DE502004007577D1 (en) Lymerpartikel
ATE485848T1 (en) COATINGS
DE602005012950D1 (en) MEDICAL PRODUCT WITH A BIOLOGICAL ACTIVE SUBSTANCE
AU2003222665A1 (en) Cardiac resynchronisation with adaptive a1-a2 and/or v1-v2 intervals
GEP20115245B (en) Solid preparation
AU2003224117A1 (en) Water-absorbing polymer particles inhibiting the breakdown of body fluids, composites comprising the same and use thereof
AU313362S (en) Applicator
AU313076S (en) Applicator
WO2006105161A3 (en) Coated medical device
AU2003257179A1 (en) Drug-loaded biological material chemically treated with genipin
ZA200205163B (en) Adhesive bandage with improved comfort and adhesion during use.
EP1762761A4 (en) Valve body and valve having the same
WO2008104528A3 (en) Implantable material comprising cellulose and the glycopeptide xyloglucan-grgds
WO2002096348A3 (en) Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
MX2007007355A (en) 5-(2,2-dimethyl-cycloprodyl)-3-methyl-pen-2-enenitrile as fragrance and flavour.
DE50301045D1 (en) CMOS-PROCESS-COMPATIBLE HIGH-DK SURFACE COATING FOR THE CAPACITIVE DETECTION AND STIMULATION OF BIOLOGICAL TISSUE
MXPA03006099A (en) Absorbent article with fluid treatment agent.
GR1003723B (en) Pultiple purpose catheter
AU2003278209A1 (en) Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances
AU309683S (en) Massaging belt
WO2004007720A3 (en) Treatment of proliferative disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase